News from MarketWatch Top Stories

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Tariffs Ceo Cryptocurrency Crypto Assets Investors Stocks Stock Stock Market Shares Ethereum Markets Price Xrp Investment Blockchain Sec Eth Etf Stablecoin Trade Earnings Revenue Solana China Index Coinbase Bse Token Nasdaq Wall Street Ipo Usd Trade War Interest Rates Inflation Economy Profit Digital Assets Sp 500 Nvidia Sensex Gold Binance Federal Reserve Treasury Nse Traders Price Levels Atm Cash App Grasim Inds Price Rallies Advertisers House Market Structure Bill Labour Suppliers Suraksha Diagnostic Uk Tax Agency

Filter by:

Treatment × Past week × MarketWatch Top Stories ×

MarketWatch Top Stories • May 30, 2025

Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure

The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...

Read Full Article →